NORDIC BIOSCIENCE A/S: Financial statements 2013
CVR: 30799968
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
NORDIC BIOSCIENCE A/S (CVR 30799968) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 15,783,274 and a net result of DKK -6,667,393. Equity in the 2013 report amounted to DKK 14,129,682. The solvency ratio was 6.4%.
- Gross Profit
- DKK 15,783,274
- Profit/Loss
- DKK -6,667,393
- Equity
- DKK 14,129,682
- Total Assets
- DKK 221,179,098
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 15.8 mio. | -6.7 mio. | 14.1 mio. | - |
| 2012 | - | - | - | - | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of October 1, 2013, BAKER TILLY DENMARK GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of NORDIC BIOSCIENCE A/S.
As of October 1, 2013, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of NORDIC BIOSCIENCE A/S.
NORDIC BIOSCIENCE A/S has published its annual report for 2012.
As of February 6, 2013, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of NORDIC BIOSCIENCE A/S.
As of February 6, 2013, Ankjær-Jensen & Partnere I/S, Statsautoriserede Revisorer has stepped down as auditor of NORDIC BIOSCIENCE A/S.
About NORDIC BIOSCIENCE A/S
NORDIC BIOSCIENCE A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Morten Asser Karsdal. The board consists of Bente Juel Christiansen, Claus Henrik Christiansen and Thomas Nielsen. The company is owned by NORDIC BIOSCIENCE HOLDING A/S. The company has 206 employees (2026). In 2025, the company reported revenue of DKK 379,345,000 and a net result of DKK 96,537,000 compared with DKK 78,388,000 the year before. Equity in the 2025 report amounted to DKK 131,205,000.